Hepatitis B reactivation after lamivudine

Lancet. 1995 Oct 28;346(8983):1156-7. doi: 10.1016/s0140-6736(95)91829-9.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Alanine Transaminase / blood
  • Antiviral Agents / adverse effects*
  • Antiviral Agents / therapeutic use
  • Hepatitis B / drug therapy*
  • Hepatitis B / immunology
  • Hepatitis B / virology*
  • Hepatitis B Core Antigens / analysis
  • Hepatitis B e Antigens / analysis
  • Hepatitis B virus / growth & development
  • Humans
  • Lamivudine
  • Male
  • Prednisone / therapeutic use
  • Recurrence
  • Virus Activation
  • Zalcitabine / adverse effects
  • Zalcitabine / analogs & derivatives*
  • Zalcitabine / therapeutic use

Substances

  • Antiviral Agents
  • Hepatitis B Core Antigens
  • Hepatitis B e Antigens
  • Lamivudine
  • Zalcitabine
  • Alanine Transaminase
  • Prednisone